UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in DNLI — Denali Therapeutics Inc.
CIK 861177
NEW YORK, NY
Position in DNLI
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$85,100,425
+$2,819,113 QoQ
Shares Held
4,432,314
-11.1% QoQ
Ownership
2.79%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 60.05641748305738.ToString("F0")%
Shared 0.ToString("F0")%
None 39.94358251694262.ToString("F0")%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. DNLI ranks #8 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
This page
|
4,432,314 | $85,100,425 |
All Filings in DNLI
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $85,100,425 | 4,432,314 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $82,281,312 | 4,983,726 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $79,352,332 | 5,465,037 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $87,609,251 | 6,262,277 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $91,996,218 | 6,766,916 | Shares | Sole | 2025-05-19 | |
| 2024-12-31 | $73,018,967 | 3,582,874 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $109,222,524 | 3,749,486 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $53,352,960 | 2,297,716 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $14,102,140 | 687,239 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $15,200,951 | 708,339 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $13,271,276 | 643,300 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $16,736,329 | 567,141 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $13,066,926 | 567,141 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $15,126,495 | 543,923 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $16,271,956 | 530,204 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $14,344,323 | 487,405 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $13,988,382 | 434,827 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $19,625,603 | 440,036 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $21,932,327 | 434,734 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $33,719,079 | 429,871 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $17,032,014 | 298,284 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $34,315,046 | 409,683 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $17,732,516 | 494,907 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $11,912,735 | 492,669 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,158,128 | 66,141 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||